{"id":1216,"date":"2024-01-16T09:00:00","date_gmt":"2024-01-16T09:00:00","guid":{"rendered":"https:\/\/lee-pharm.com\/the-groups-in-house-developed-product-socazolimab-injection-was-successfully-launched-in-china\/"},"modified":"2026-09-24T09:22:08","modified_gmt":"2026-09-24T09:22:08","slug":"the-groups-in-house-developed-product-socazolimab-injection-was-successfully-launched-in-china","status":"publish","type":"post","link":"https:\/\/lee-pharm.com\/en\/the-groups-in-house-developed-product-socazolimab-injection-was-successfully-launched-in-china\/","title":{"rendered":"The Group\u2019s in-house developed product Socazolimab Injection was successfully launched in China"},"content":{"rendered":"

January 15, 2024, Lee\u2019s Pharmaceutical Holdings Limited (\u201cLee\u2019s Pharm\u201d or \u201cthe Group\u201d, HKEx:00950) announced that its in-house developed product Socazolimab Injection, was successfully launched in China and was distributed from its Guangzhou Nansha manufacturing site across the country.<\/p>\n